Perimeter Medical Imaging AI, Inc. (PINK.V)
CAD 0.43
(6.25%)
CAD 0.43
(6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -17.91 Million CAD | -39.96% |
| 2022 | -11.71 Million USD | 3.97% |
| 2021 | -15.95 Million CAD | -37.3% |
| 2020 | -6.1 Million CAD | 10.39% |
| 2019 | -7 Million CAD | -11156.37% |
| 2018 | -115.2 Thousand CAD | 6.68% |
| 2017 | -123.44 Thousand CAD | 10.01% |
| 2016 | -137.17 Thousand CAD | 25.62% |
| 2015 | -184.42 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.37 Million USD | 50.54% |
| 2024 Q2 | -5.04 Million USD | -13.44% |
| 2023 Q2 | -2.75 Million USD | 22.75% |
| 2023 Q1 | -3.56 Million USD | 5.61% |
| 2023 FY | - CAD | -39.96% |
| 2023 Q4 | -4.58 Million USD | -14.59% |
| 2023 Q3 | -4 Million USD | -45.22% |
| 2022 Q3 | -5.4 Million CAD | 6.4% |
| 2022 Q1 | -4.6 Million CAD | 15.76% |
| 2022 Q2 | -5.77 Million CAD | -25.22% |
| 2022 FY | - USD | 3.97% |
| 2022 Q4 | -3.78 Million USD | 29.99% |
| 2021 Q1 | -3.78 Million CAD | 34.71% |
| 2021 Q2 | -3.01 Million CAD | 20.37% |
| 2021 Q3 | -3.69 Million CAD | -22.53% |
| 2021 Q4 | -5.47 Million CAD | -48.18% |
| 2021 FY | - CAD | -37.3% |
| 2020 Q1 | -1.7 Million CAD | 69.78% |
| 2020 Q3 | -2.15 Million CAD | -63.67% |
| 2020 Q4 | -5.79 Million CAD | -169.11% |
| 2020 Q2 | -1.31 Million CAD | 22.61% |
| 2020 FY | - CAD | 10.39% |
| 2019 Q1 | -1.55 Million CAD | 0.0% |
| 2019 FY | - CAD | -11156.37% |
| 2019 Q4 | -5.62 Million CAD | -149.73% |
| 2019 Q3 | -2.25 Million CAD | -5.34% |
| 2019 Q2 | -2.13 Million CAD | -37.8% |
| 2018 FY | - CAD | 6.68% |
| 2017 FY | - CAD | 10.01% |
| 2016 FY | - CAD | 25.62% |
| 2015 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Therma Bright Inc. | -3.67 Million CAD | -387.083% |
| Theralase Technologies Inc. | -4.25 Million CAD | -321.206% |
| VentriPoint Diagnostics Ltd. | -4.73 Million CAD | -278.15% |